Huma Qamar - 16 Apr 2024 Form 4 Insider Report for Ocugen, Inc. (OCGN)

Role
Chief Medical Officer
Signature
/s/ Huma Qamar
Issuer symbol
OCGN
Transactions as of
16 Apr 2024
Net transactions value
$0
Form type
4
Filing time
17 Apr 2024, 17:41:24 UTC
Previous filing
20 Mar 2024
Next filing
06 Jan 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OCGN Option (Right to Buy) Award $0 +308,465 $0.000000 308,465 16 Apr 2024 Common Stock 308,465 $1.59 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests annually in equal installments over three years commencing on April 16, 2025, subject to continued service with the Issuer on the applicable vesting dates.